1
0
Andrada M y cols. Resultados de una encuesta sobre el estado actual de gastrectomía D2 laparocópica . Rev Argent Cir. 2025;117(3):e-1805
for diagnosis, treatment and follow -up. Ann Oncol. 2016;27(suppl
):v38 -49.
Distal Gastrectomy for Advanced Gastric Cancer: The JLSSG0901
Randomized Clinical Trial. JAMA Surg. 2023 May 1;158(5):445-
454.
5
6
.
Khuri SF, Daley J, Henderson W, Hur K, Demakis J, Aust JB, et al.
The Department of Veterans Affairs' NSQIP: the first naꢀonal,
validated, outcome-based, risk-adjusted, and peer-controlled
program for the measurement and enhancement of the quality of
surgical care. Naꢀonal VA Surgical Quality Improvement Program.
Ann Surg. 1998 Oct;228(4):491-507. doi: 10.1097/00000658-
17. Yuan P, Yan Y, Jia Y, Wang J, Li Z, Wu Q. Intraoperaꢀve gastroscopy to
determine proximal resecꢀon margin during totally laparoscopic
gastrectomy for paꢀents with upper third gastric cancer. J
Gastrointest Oncol. 2021 Feb;12(1):142 -152.
18. Kawakatsu S, Ohashi M, Hiki N, Nunobe S, Nagino M, Sano T. Use of
endoscopy to determine the resecꢀon margin during laparoscopic
gastrectomy for cancer. Br J Surg. 2017 Dec;104(13):1829 -1836.
19. Jeong SH, Seo KW, Min JS. Intraoperaꢀve Tumor Localizaꢀon of
Early Gastric Cancers. J Gastric Cancer. 2021 Mar;21(1):4 -15.
20. Park SH, Lee HJ, Park JH, Kim TH, Son YG, Huh YJ, et al. Clinical
Significance of Intra <operaꢀve Gastroscopy for Tumor Localizaꢀon
in Totally Laparoscopic Parꢀal Gastrectomy. J Gastrointest Surg.
2021 May;25(5):1134 -1146.
1
99810000-00006. PMID: 9790339; PMCID: PMC1191523.
7
8
.
.
.
Ingraham AM, Richards KE, Hall BL, Ko CY. Quality improvement
in surgery: the American College of Surgeons Naꢀonal Surgical
Quality Improvement Program approach. Adv Surg 2010; 44: 251-
2
67. doi: 10.1016/j.yasu.2010.05.003.
Cohen ME, Liu Y, Ko CY, Hall BL. Improved Surgical Outcomes for
ACS NSQIP Hospitals Over Time: Evaluaꢀon of Hospital Cohorts
With up to 8 years of Parꢀcipaꢀon. Ann Surg 2016; 263: 267 -273.
doi: 10.1097/SLA.0000000000001192.
21. Makris EA, Poultsides GA. Surgical Consideraꢀons in the
Management of Gastric Adenocarcinoma. Surg Clin North Am.
2017 Apr;97(2):295 -316.
9
1
1
Van Leersum NJ, Snijders HS, Henneman D, Kolfschoten NE,
Gooiker GA, ten Berge MG et al The Dutch surgical colorectal
audit. Eur J Surg Oncol 2013; 39: 1063 -1070.
22. van der Wielen N, Straatman J, Daams F, Rosaꢀ R, Parise P, Weitz
J, et al. Open versus minimally invasive total gastrectomy aꢄer
neoadjuvant chemotherapy: results of a European randomized
trial. Gastric Cancer. 2021 Jan;24(1):258 -271.
0. Moser F, Obeide L, Signorini FJ. Videolaparoscopía como primera
elección de tratamiento en la patología quirúrgica del tubo
digesꢀvo. Rev Argent Cir. 2022; 114(Suplemento 1): S47-S160.
1. Ji J, Shi L, Ying X, Lu X, Shan F. Associaꢀons of Annual Hospital
and Surgeon Volume with Paꢀent Outcomes Aꢄer Gastrectomy:
A Systemaꢀc Review and Meta -analysis. Ann Surg Oncol. 2022
Dec;29(13):8276 -8297. doi: 10.1245/s10434-022-12515-y. Epub
23. Illuminaꢀ G, D'Urso A, Fiori E, Cerasari S, Nardi P, Lapergola A,
et al. Laparoscopy -assisted vs open total gastrectomy with
D2 lymphadenectomy for advanced gastric cancer: results
of
a retrospecꢀve, mulꢀcenter study. Updates Surg. 2023
2
022 Sep 15. PMID: 36109408.
Sep;75(6):1645 -1651
1
1
2. Kang YK, Yook JH, Park YK, Lee JS, Kim Y-W, Kim JY et al. PRODIGY:
a phase III study of neoadjuvant docetaxel, oxaliplaꢀn, and S -1
plus surgery and adjuvant S-1 versus surgery and adjuvant S -1 for
resectable advanced gastric cancer. J Clin Oncol. 2021; 39:2903–
24. Brisinda G, Chiarello MM, Crocco A, Adams NJ, Fransvea P,
Vanella S. Postoperaꢀve mortality and morbidity aꢄer D2
lymphadenectomy for gastric cancer: A retrospecꢀve cohort
study. World J Gastroenterol. 2022 Jan 21;28(3):381 -398.
25. Hyung WJ, Yang HK, Han SU, Lee YJ, Park JM, Kim JJ, et al. A
feasibility study of laparoscopic total gastrectomy for clinical stage
I gastric cancer: a prospecꢀve mulꢀ -center phase II clinical trial,
KLASS 03. Gastric Cancer. 2019;22(1):214–22.
2
913. doi: 10.1200/JCO.20.02914.
3. Zhang X, Liang H, Li Z, Xue Y, Wang Y, Zhou Z et al. Perioperaꢀve
or postoperaꢀve adjuvant oxaliplaꢀn with S <1 versus adjuvant
oxaliplaꢀn with capecitabine in paꢀents with locally advanced
gastric or gastro-oesophageal juncꢀon adenocarcinoma
undergoing D2 gastrectomy (RESOLVE): an open <label, superiority
and non <inferiority, phase 3 randomised controlled trial. Lancet
Oncol. 2021;22(8):1081–1092.
26. Li SS, Costanꢀno CL, Mullen JT. Morbidity and Mortality of Total
Gastrectomy: a Comprehensive Analysis of 90-Day Outcomes. J
Gastrointest Surg. 2019; 23:1340 -1348.
27. Van der Veen A, Brenkman HJF, Seesing MFJ, Haverkamp L,
Luyer MDP, Nieuwenhuijzen GAP, et al. LOGICA Study Group.
Laparoscopic Versus Open Gastrectomy for Gastric Cancer
(LOGICA): A Mulꢀcenter Randomized Clinical Trial. J Clin Oncol.
2021 Mar 20;39(9):978 -989.
28. Desiderio J, Sagnoꢆa A, Terrenato I, Garofoli E, Mosillo C,
Trastulli S, et al. Long -term survival of paꢀents with stage II and
III gastric cancer who underwent gastrectomy with inadequate
nodal assessment. World J Gastrointest Surg. 2021, 13(11):
1463–1483.
1
1
1
4. Japanese Gastric Cancer Associaꢀon. Japanese Gastric Cancer
Treatment Guidelines 2021 (6th ediꢀon). Gastric Cancer. 2023
Jan;26(1):1 -25
5. Rausei S, Boni L, Rovera F, Dionigi G. Locally advanced
gastric cancer: a new definiꢀon to standardize. J Clin Pathol.
2
013;66(2):164 -165.
6. Etoh T, Ohyama T, Sakuramoto S, Tsuji T, Lee SW, Yoshida K, et
al. Japanese Laparoscopic Surgery Study Group (JLSSG). Five
-Year Survival Outcomes of Laparoscopy -Assisted vs Open